Strategy for salvaging infected breast implants: lessons from the recovery of seven consecutive patients

Background In recent years, implant-based breast reconstruction has been performed because of its simplicity, short operation time, and rapid recovery of patients. Several studies have reported treatment methods for implant surgery-related infection, which is a serious complication. The aim of this study was to introduce our strategy for salvaging infected implants and to evaluate its effectiveness.

Methods The authors performed a retrospective study of 145 cases from 132 patients who underwent implant-based breast reconstruction from January 2012 to December 2018. Empirical antibiotics were immediately administered to patients with suspected infections. The patients then underwent salvage treatment including appropriate antibiotics, ultrasonography-guided aspiration, debridement, antibiotic lavage, and implant exchange through a multidisciplinary approach. Patient demographics, operative data, duration until drain removal, adjuvant treatment, and complications were analyzed.

Results The total infection rate was 5.5% (8/145). A longer indwelling catheter period and adjuvant treatment were significantly associated with infection. The salvage treatment showed a success rate of 87.5% (7/8). Seven patients who received early aggressive salvage treatment recovered from infection. One patient with methicillin-resistant Staphylococcus aureus, who received salvage treatment 11 days after symptom onset, did not respond to drainage and antibiotic treatment. That patient subsequently underwent explantation.

Conclusions In implant-based breast reconstruction, prevention of infection is of the utmost importance. However, if an infection is suspected, proactive empirical antibiotic therapy and collaboration with the necessary departments are required. Through a multidisciplinary approach and proactive early management, swift and appropriate salvage should be performed.

Keywords

Mammaplasty - Breast implants - Infections - Salvage therapy - Interdisciplinary studies

Publication History

Received: 10 August 2020

Accepted: 13 December 2020

Article published online:
07 March 2022

• REFERENCES

• 1 American Society of Plastic Surgeons (ASPS). 2018 Plastic surgery statistics report [Internet]. Arlington Heights, IL: ASPS; c2019 [cited 2021 Mar 9]. Available from: Available at: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-full-report-2018.pdf
• 2 Brown MH, Shenker R, Silver SA. Cohesive silicone gel breast implants in aesthetic and reconstructive breast surgery. Plast Reconstr Surg 2005; 116: 768-79
• 3 Kim JB, Jeon HJ, Lee JW. et al. A murine model of radiationinduced capsule-tissue reactions around smooth silicone implants. J Plast Surg Hand Surg 2018; 52: 217-24
• 4 Araco A, Gravante G, Araco F. et al. A retrospective analysis of 3,000 primary aesthetic breast augmentations: postoperative complications and associated factors. Aesthetic Plast Surg 2007; 31: 532-9
• 5 Sullivan SR, Fletcher DR, Isom CD. et al. True incidence of all complications following immediate and delayed breast reconstruction. Plast Reconstr Surg 2008; 122: 19-28
• 6 Cordeiro PG, McCarthy CM. A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part I. a prospective analysis of early complications. Plast Reconstr Surg 2006; 118: 825-31
• 7 De Cholnoky T. Augmentation mammaplasty: survey of complications in 10,941 patients by 265 surgeons. Plast Reconstr Surg 1970; 45: 573-7
• 8 Warren Peled A, Itakura K, Foster RD. et al. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg 2010; 145: 880-5
• 9 Leyngold MM, Stutman RL, Khiabani KT. et al. Contributing variables to post mastectomy tissue expander infection. Breast J 2012; 18: 351-6
• 10 Chun JK, Schulman MR. The infected breast prosthesis after mastectomy reconstruction: successful salvage of nine implants in eight consecutive patients. Plast Reconstr Surg 2007; 120: 581-9
• 11 Prince MD, Suber JS, Aya-Ay ML. et al. Prosthesis salvage in breast reconstruction patients with periprosthetic infection and exposure. Plast Reconstr Surg 2012; 129: 42-8
• 12 Lee JS, Kim JS, Lee JH. et al. Prepectoral breast reconstruction with complete implant coverage using double-crossed acellular dermal matrixs. Gland Surg 2019; 8: 748-57
• 13 Alderman AK, Wilkins EG, Kim HM. et al. Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg 2002; 109: 2265-74
• 14 Gabriel SE, Woods JE, O’Fallon WM. et al. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336: 677-82
• 15 Spear SL, Seruya M. Management of the infected or exposed breast prosthesis: a single surgeon’s 15-year experience with 69 patients. Plast Reconstr Surg 2010; 125: 1074-84
• 16 Courtiss EH, Goldwyn RM, Anastasi GW. The fate of breast implants with infections around them. Plast Reconstr Surg 1979; 63: 812-6
• 17 Reish RG, Damjanovic B, Austen Jr WG. et al. Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 2013; 131: 1223-30
• 18 Trop I, Dugas A, David J. et al. Breast abscesses: evidencebased algorithms for diagnosis, management, and follow-up. Radiographics 2011; 31: 1683-99
• 19 Schlarb D, Idelevich EA, Krause-Bergmann A. et al. Successful interdisciplinary radical treatment of Mycobacterium fortuitum infection in a lipotourist from Germany after abdominoplasty in Turkey. New Microbes New Infect 2015; 8: 21-3
• 20 Feldman EM, Kontoyiannis DP, Sharabi SE. et al. Breast implant infections: is cefazolin enough?. Plast Reconstr Surg 2010; 126: 779-85
• 21 Song JH, Kim YS, Jung BK. et al. Salvage of infected breast implants. Arch Plast Surg 2017; 44: 516-22
• 22 Yii NW, Khoo CT. Salvage of infected expander prostheses in breast reconstruction. Plast Reconstr Surg 2003; 111: 1087-92